Evommune, Inc. (EVMN)
Market Closed
17 Jul, 20:00
NYSE NYSE Primary $
12. 14
+0.43
+3.6721%
$
187.11M Market Cap
- P/E Ratio
- Div Yield
769,800 Volume
- Eps
$ 11.71
Previous Close 
Want to track EVMN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Evommune, Inc. (EVMN) Statistics
Valuation metrics
Market Cap 187.11M
Enterprise value 132.75M
Trailing P/E (ttm) -5.08
Forward P/E -
PEG ratio 0.19
Price/Sales (ttm) 17.2
Price/Book (mrq) 1.34
Enterprise Value/Revenue 13.28
Enterprise Value/EBITDA -1.78
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 892.31K
Average volume (90 days) 823.89K
Price summary
52-Week low 11.5
52-Week high 33.2
Beta -
50-Day moving average 15.78
200-Day moving average 22.9
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -7.6%
Operating margin -9%
Operational effectiveness
Return on assets -0.24%
Return on equity -1.95%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.3
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.26
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.28
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 20.36%
Book value per share (mrq) 9.05
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
